BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11124802)

  • 1. TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest.
    Petritsch C; Beug H; Balmain A; Oft M
    Genes Dev; 2000 Dec; 14(24):3093-101. PubMed ID: 11124802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3.
    Wilkes MC; Murphy SJ; Garamszegi N; Leof EB
    Mol Cell Biol; 2003 Dec; 23(23):8878-89. PubMed ID: 14612425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor.
    Rotzer D; Roth M; Lutz M; Lindemann D; Sebald W; Knaus P
    EMBO J; 2001 Feb; 20(3):480-90. PubMed ID: 11157754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and functional interactions between type I transforming growth factor beta receptors and Balpha, a WD-40 repeat subunit of phosphatase 2A.
    Griswold-Prenner I; Kamibayashi C; Maruoka EM; Mumby MC; Derynck R
    Mol Cell Biol; 1998 Nov; 18(11):6595-604. PubMed ID: 9774674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internalization-dependent and -independent requirements for transforming growth factor beta receptor signaling via the Smad pathway.
    Penheiter SG; Mitchell H; Garamszegi N; Edens M; Doré JJ; Leof EB
    Mol Cell Biol; 2002 Jul; 22(13):4750-9. PubMed ID: 12052882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of TGF-β Receptor-2 Expression and Signaling through Inhibition of Na/K-ATPase.
    La J; Reed E; Chan L; Smolyaninova LV; Akomova OA; Mutlu GM; Orlov SN; Dulin NO
    PLoS One; 2016; 11(12):e0168363. PubMed ID: 28006004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between TGF-β and EGF receptors via direct phosphorylation.
    Moustakas A
    J Cell Biol; 2024 Apr; 223(4):. PubMed ID: 38506732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mysteries of TGF-β Paradox in Benign and Malignant Cells.
    Zhang Q; Yu N; Lee C
    Front Oncol; 2014; 4():94. PubMed ID: 24860782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the substrate landscape of protein phosphatase 2A catalytic subunit PPP2CA.
    Brewer A; Sathe G; Pflug BE; Clarke RG; Macartney TJ; Sapkota GP
    iScience; 2024 Mar; 27(3):109302. PubMed ID: 38450154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Far-Infrared Irradiation Decreases Proliferation in Basal and PDGF-Stimulated VSMCs Through AMPK-Mediated Inhibition of mTOR/p70S6K Signaling Axis.
    Hwang YJ; Park JH; Cho DH
    J Korean Med Sci; 2023 Oct; 38(41):e335. PubMed ID: 37873631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The B56γ3-containing protein phosphatase 2A attenuates p70S6K-mediated negative feedback loop to enhance AKT-facilitated epithelial-mesenchymal transition in colorectal cancer.
    Hsiao KC; Ruan SY; Chen SM; Lai TY; Chan RH; Zhang YM; Chu CA; Cheng HC; Tsai HW; Tu YF; Law BK; Chang TT; Chow NH; Chiang CW
    Cell Commun Signal; 2023 Jul; 21(1):172. PubMed ID: 37430297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric Dimethylation of Ribosomal S6 Kinase 2 Regulates Its Cellular Localisation and Pro-Survival Function.
    Khalil MI; Ismail HM; Panasyuk G; Bdzhola A; Filonenko V; Gout I; Pardo OE
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonic organizer formation disorder leads to multiorgan dysplasia in Down syndrome.
    Liu Y; Lin Z; Peng Y; Jiang Y; Zhang X; Zhu H; Zhang L; Chen J; Shu X; Luo M; Xie D; Chen Y; Liao H; Liu M; Zhang X; Liu S; Wang H; Zhou B; Sun H
    Cell Death Dis; 2022 Dec; 13(12):1054. PubMed ID: 36535930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond controlling cell size: functional analyses of S6K in tumorigenesis.
    Wu X; Xie W; Xie W; Wei W; Guo J
    Cell Death Dis; 2022 Jul; 13(7):646. PubMed ID: 35879299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP-3 and TGF-β inhibit growth in epithelial cells by stimulating type V TGF-β receptor (TβR-V)-mediated tumor suppressor signaling.
    Chen CL; Huang FW; Huang SS; Huang JS
    FASEB Bioadv; 2021 Sep; 3(9):709-729. PubMed ID: 34485840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of TGF-
    Yang Y; Ye WL; Zhang RN; He XS; Wang JR; Liu YX; Wang Y; Yang XM; Zhang YJ; Gan WJ
    Evid Based Complement Alternat Med; 2021; 2021():6675208. PubMed ID: 34335834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFB1/INHBA Homodimer/Nodal-SMAD2/3 Signaling Network: A Pivotal Molecular Target in PDAC Treatment.
    Abdel Mouti M; Pauklin S
    Mol Ther; 2021 Mar; 29(3):920-936. PubMed ID: 33429081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of YAP and Its Related Mechanisms in Central Nervous System Diseases.
    Jin J; Zhao X; Fu H; Gao Y
    Front Neurosci; 2020; 14():595. PubMed ID: 32676008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tgfb3 collaborates with PP2A and notch signaling pathways to inhibit retina regeneration.
    Lee MS; Wan J; Goldman D
    Elife; 2020 May; 9():. PubMed ID: 32396062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic Profiling of DAF-7/TGFβ Pathway Mutants in
    Hu M; Crossman D; Prasain JK; Miller MA; Serra RA
    Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32182864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.